Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

E-cigarette additives increase inflammation and impair lung function, study finds

Flavouring and additive ingredients in e-cigarettes may increase inflammation and impair lung function, according to new research.

The study, published ahead of print in the American Journal of Physiology--Lung Cellular and Molecular Physiology, also found that short-term exposure to e-cigarettes was enough to cause lung inflammation similar or worse than that seen in traditional cigarette use.

The research was chosen as an APSselect article for October.

E-cigarettes, popular battery-powered devices that simulate the act of smoking a traditional cigarette, dispense a vapour derived from liquid chemicals in a refillable cartridge.

The refills typically contain propylene glycol, nicotine and often flavourings.

Propylene glycol--a colourless, odourless food additive--is found in numerous processed food and beverages; it is also used as a solvent in a number pharmaceuticals.

E-cigarette devices and refills are not well regulated, and the long-term health effects of e-cigarette use are not widely known.

Researchers studied several groups of mice that received whole-body exposure to varying chemical combinations four times each day.

Each exposure session was separated by 30-minute smoke-free intervals.

  • One group was exposed to cigarette smoke ("cigarette");
  • One group was exposed to e-cigarette vapour containing propylene glycol and vegetable glycerol, an odourless liquid derived from plant oils ("propylene");
  • One group was exposed to e-cigarette vapour containing propylene glycol and nicotine ("propylene nicotine") and
  • One group was exposed to e-cigarette vapour containing propylene glycol, nicotine and tobacco flavouring ("flavouring").

The cigarette and e-cigarette groups were compared with a control group that was exposed to medical-grade air.

Some of the animals in each group were exposed to short-term cigarette smoke or e-cigarette vapour (three days), while others were exposed for a longer term (four weeks).

The research team found an increase in markers of inflammation, mucus production and altered lung function in the propylene, propylene nicotine and flavouring groups after three days.

However, the propylene group showed fewer negative effects with long-term exposure, suggesting the additive alone elicits only a temporary irritation that eventually subsides with continued use.

In addition, two inflammation-producing proteins became elevated only in the flavouring group, suggesting that some of the many flavouring components on the market may not be safe for even short-term use.

The condition of the e-cigarette groups in comparison with the cigarette group surprised the researchers.

The level of oxidative stress--stress at a cellular level--in the flavouring group was equal to or higher than that of the cigarette group.

However, respiratory mechanics were adversely affected only in mice exposed to cigarette smoke and not to e-cigarette vapour after prolonged treatment. "The observed detrimental effects in the lung upon [e-cigarette] vapour exposure in animal models highlight the need for further investigation of safety and toxicity of these rapidly expanding devices worldwide," the researchers wrote.

Source: American Physiological Society



Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation